Experts plan clinical trial to test treatments for withdrawal syndrome.
Bethesda, Maryland—(ENEWSPF)—October 2, 2017
Authored by: National Institutes of Health
The National Institutes of Health is funding a new study to evaluate treatment options for newborns with opioid withdrawal syndrome, a condition caused by exposure to opioids during pregnancy. Currently, health care providers in the United States lack standard, evidence-based treatments for neonatal opioid withdrawal syndrome, despite states reporting more cases (link is external) in recent years. The study, called Advancing Clinical Trials in . . .